Skip to main content

Health Outcomes Associated With Clinician-initiated Delivery for Hypertensive Disorders at 34-38 Weeks' Gestation.

Publication ,  Journal Article
Savitz, DA; Danilack, VA; Cochancela, J; Hughes, BL; Rouse, DJ; Gutmann, R
Published in: Epidemiology
March 1, 2022

BACKGROUND: Clinicians caring for the nearly 10% of patients in the United States with nonsevere hypertensive disorders in late pregnancy need better evidence to balance risks and benefits of clinician-initiated delivery. METHODS: We conducted a record-based cohort study of maternal and infant health outcomes among deliveries from 2002-2013 at Women & Infants Hospital of Rhode Island. Participants had gestational hypertension or nonsevere preeclampsia before 39 weeks' gestation (N=4,295). For each gestational week from 34 to 38, we compared outcomes between clinician-initiated deliveries (induction of labor or prelabor cesarean) and those not initiated in that week, using propensity score models to control confounding by indication. RESULTS: The analysis predicted an increment in risk of adverse maternal and infant outcomes sustained through week 37 if all patients underwent clinician-initiated delivery, with risk differences on the order of 0.2 for maternal outcomes and 0.3 for infant outcomes weeks 34 and 35. For women undergoing clinician-initiated delivery, the analysis identified increased risk of progression to severe disease in weeks 35 and 36, increases in all adverse infant outcomes only in week 34, increases in Neonatal Intensive Care Unit admission and infant hospital stay in weeks 35 and 36, and no meaningful increase in any of the adverse outcomes in weeks 37 or 38. CONCLUSIONS: We estimate that hypertensive pregnancies chosen for intervention were minimally harmed by early delivery after 34 weeks' gestation but predict benefit from extension to 37 weeks. Our study also showed adverse infant health consequences associated with routine delivery prior to 37 weeks.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Epidemiology

DOI

EISSN

1531-5487

Publication Date

March 1, 2022

Volume

33

Issue

2

Start / End Page

260 / 268

Location

United States

Related Subject Headings

  • United States
  • Pregnancy
  • Outcome Assessment, Health Care
  • Labor, Obstetric
  • Infant, Newborn
  • Infant
  • Hypertension, Pregnancy-Induced
  • Humans
  • Gestational Age
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Savitz, D. A., Danilack, V. A., Cochancela, J., Hughes, B. L., Rouse, D. J., & Gutmann, R. (2022). Health Outcomes Associated With Clinician-initiated Delivery for Hypertensive Disorders at 34-38 Weeks' Gestation. Epidemiology, 33(2), 260–268. https://doi.org/10.1097/EDE.0000000000001442
Savitz, David A., Valery A. Danilack, Jerson Cochancela, Brenna L. Hughes, Dwight J. Rouse, and Roee Gutmann. “Health Outcomes Associated With Clinician-initiated Delivery for Hypertensive Disorders at 34-38 Weeks' Gestation.Epidemiology 33, no. 2 (March 1, 2022): 260–68. https://doi.org/10.1097/EDE.0000000000001442.
Savitz DA, Danilack VA, Cochancela J, Hughes BL, Rouse DJ, Gutmann R. Health Outcomes Associated With Clinician-initiated Delivery for Hypertensive Disorders at 34-38 Weeks' Gestation. Epidemiology. 2022 Mar 1;33(2):260–8.
Savitz, David A., et al. “Health Outcomes Associated With Clinician-initiated Delivery for Hypertensive Disorders at 34-38 Weeks' Gestation.Epidemiology, vol. 33, no. 2, Mar. 2022, pp. 260–68. Pubmed, doi:10.1097/EDE.0000000000001442.
Savitz DA, Danilack VA, Cochancela J, Hughes BL, Rouse DJ, Gutmann R. Health Outcomes Associated With Clinician-initiated Delivery for Hypertensive Disorders at 34-38 Weeks' Gestation. Epidemiology. 2022 Mar 1;33(2):260–268.

Published In

Epidemiology

DOI

EISSN

1531-5487

Publication Date

March 1, 2022

Volume

33

Issue

2

Start / End Page

260 / 268

Location

United States

Related Subject Headings

  • United States
  • Pregnancy
  • Outcome Assessment, Health Care
  • Labor, Obstetric
  • Infant, Newborn
  • Infant
  • Hypertension, Pregnancy-Induced
  • Humans
  • Gestational Age
  • Female